IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, CENTRAL LAB AND BIOREPOSITORY (CLB), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018

国家骨髓增生异常综合征自然病史研究中心实验室和生物库(国家MDS研究CL/B)的目标是提供必要的科学知识、技术专长和实验室设施，以设计、建造和存储高质量的生物标本收集。国家MDS研究是一项为期七年的观察性研究，涉及2000名新诊断为MDS的成年人和多达500名年龄匹配的参与者，他们没有被诊断为MDS，但临床上被怀疑患有这种综合征。国家MDS研究将由一个由单独合同资助的数据协调中心(DCC)和一个CL/B组成。项目的总体协调将由DCC执行。

The objective of the National Myelodysplastic Syndromes Natural History Study Central Laboratory and Biorepository (The National MDS Study CL/B) is to provide the necessary scientific knowledge, technical expertise and laboratory facilities to design, build, and store a quality biospecimen collection. The National MDS Study is a seven year observational study of 2000 adults newly diagnosed with MDS and up to 500 age-matched participants who are not diagnosed with MDS, but who are clinically suspected of having this syndrome. The National MDS Study will be comprised of one Data Coordinating Center (DCC) funded under a separate contract and one CL/B. Overall coordination of the program will be performed by the DCC.